This article was originally published in The Gray Sheet
Executive SummaryFormer U.S. Sen. Connie Mack (R-Fla.) is nominated to firm's board of directors, subject to election at the annual meeting in May, Exact announces April 5. Mack was a strong advocate for federal support of medical research during his tenure in Congress. The Florida Republican served on the Senate Finance committee and was co-chairman of the Senate cancer coalition
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.